Total Payments
$1,459
2021 Payments
$145.78
Companies
20
Transactions
98
Medicare Patients
653
Medicare Billing
$50,172
Payment Breakdown by Category
Food & Beverage$1,424 (97.6%)
Education$34.95 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,424 | 97 | 97.6% |
| Education | $34.95 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $311.02 | 23 | $0 (2021) |
| Amgen Inc. | $246.74 | 15 | $0 (2019) |
| PFIZER INC. | $121.62 | 8 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $102.03 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $88.74 | 6 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.26 | 5 | $0 (2021) |
| Lilly USA, LLC | $79.74 | 5 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $63.51 | 4 | $0 (2020) |
| Gilead Sciences, Inc. | $62.98 | 3 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $53.27 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $145.78 | 8 | Lilly USA, LLC ($42.16) |
| 2020 | $244.98 | 16 | Gilead Sciences, Inc. ($62.98) |
| 2019 | $625.42 | 42 | Novo Nordisk Inc ($128.93) |
| 2018 | $411.20 | 30 | Amgen Inc. ($115.36) |
| 2017 | $31.86 | 2 | Amgen Inc. ($16.66) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: DIABETES | ||||||
| 04/15/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 03/16/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: WOMENS HEALTH | ||||||
| 03/15/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Obesity | ||||||
| 02/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: Diabetes | ||||||
| 01/22/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLUJAN | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Cardiovascular | ||||||
| 11/13/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.96 | General |
| 09/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/09/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.90 | General |
| 07/07/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Endocrinology | ||||||
| 06/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: Cardiovascular | ||||||
| 06/12/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLUJAN | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/08/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.12 | General |
| 03/25/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/03/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: DIABETES | ||||||
| 02/27/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 02/01/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Central Nervous System | ||||||
| 01/24/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: RESPIRATORY | ||||||
| 01/16/2020 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 12/13/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 52 | 111 | $7,395 | $3,057 |
| 2021 | 6 | 212 | 417 | $40,123 | $17,540 |
| 2020 | 12 | 389 | 553 | $71,026 | $29,574 |
Total Patients
653
Total Services
1,081
Medicare Billing
$50,172
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 35 | 89 | $6,130 | $2,425 | 39.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 22 | $1,265 | $632.71 | 50.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 48 | 200 | $10,060 | $6,120 | 60.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 29 | 29 | $6,380 | $3,787 | 59.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 66 | $9,900 | $2,941 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 50 | $10,250 | $2,742 | 26.7% |
| 99439 | Chronic care management services, each additional 20 minutes of clinical staff time per calendar month | Office | 2021 | 23 | 57 | $2,933 | $1,678 | 57.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $600.00 | $273.15 | 45.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 149 | $30,545 | $8,816 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 55 | 55 | $12,100 | $6,247 | 51.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 60 | 90 | $13,500 | $4,000 | 29.6% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 34 | 114 | $5,700 | $3,606 | 63.3% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2020 | 12 | 12 | $2,680 | $2,612 | 97.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 25 | 25 | $1,555 | $1,470 | 94.5% |
| 99487 | Complex chronic care management services 60 minutes clinical staff time | Office | 2020 | 19 | 21 | $2,100 | $1,373 | 65.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 17 | $1,360 | $557.07 | 41.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 31 | 31 | $775.00 | $497.81 | 64.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 17 | 17 | $425.00 | $272.27 | 64.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2020 | 11 | 11 | $165.00 | $68.05 | 41.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2020 | 11 | 11 | $121.00 | $56.58 | 46.8% |
About Philip Burton
Philip Burton is a Family Medicine healthcare provider based in Wake Forest, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093742017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Philip Burton has received a total of $1,459 in payments from pharmaceutical and medical device companies, with $145.78 received in 2021. These payments were reported across 98 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,424).
As a Medicare-enrolled provider, Burton has provided services to 653 Medicare beneficiaries, totaling 1,081 services with total Medicare billing of $50,172. Data is available for 3 years (2020–2022), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wake Forest, NC
- Active Since 06/26/2006
- Last Updated 02/25/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093742017
Products in Payments
- Ozempic (Drug) $186.39
- Prolia (Biological) $114.23
- FARXIGA (Drug) $88.74
- Aimovig (Biological) $78.87
- XIFAXAN (Drug) $73.76
- JARDIANCE (Drug) $72.23
- TRULICITY (Drug) $67.90
- LANTUS (Drug) $48.71
- EUCRISA (Drug) $45.85
- Victoza (Drug) $42.20
- Tresiba (Drug) $40.49
- VYVANSE (Drug) $40.34
- Vascepa (Drug) $39.39
- JANUVIA (Drug) $38.45
- PREVNAR - 13 (Biological) $37.72
- Repatha (Biological) $37.45
- BYSTOLIC (Drug) $35.45
- TRULANCE (Drug) $28.27
- CHANTIX (Drug) $25.23
- UBRELVY (Drug) $18.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wake Forest
Kofi Bruce Mensah, Md, MD
Family Medicine — Payments: $17,120
Family Medicine $17,120
Dr. Manuel Bulauitan, M.d, M.D
Family Medicine — Payments: $3,496
Family Medicine $3,496
Tida Lam, D.o, D.O
Family Medicine — Payments: $2,837
Family Medicine $2,837
Michael Hong, Do, DO
Family Medicine — Payments: $2,439
Family Medicine $2,439
Latonja Ivery, M. D, M. D
Family Medicine — Payments: $2,175
Family Medicine $2,175
Thomas Weber, Md, MD
Family Medicine — Payments: $1,530
Family Medicine $1,530